9th Annual Biomarkers Congress

View Profile


Speaking/Presenting-Abstract/Poster at Mtg

Topic Authors / presenters Event name Event date
1. The Current Role of Tri-Modality Therapy in Stage III Non-Small Cell Lung Cancer 50th Annual Meeting of the American Society for Therapeutic Radiology and Oncology September, 2008
2. Innovations in Head and Neck Radiotherapy annual meeting of the American College of Surgeons 2007 October, 2007
3. Clinical Utilization of IMRT in Head and Neck Cancer 49th Annual Meeting of the American Society for Therapeutic Radiology and Oncology October, 2007
4. GCC 0442: A Phase II Trial Evaluating the Efficacy of Weekly Cetuximab, Paclitaxel, Carboplatin and Daily RT in Locally Advanced SCCHN ASTRO’s Multidisciplinary Head and Neck Symposium January, 2007
5. A Phase II Trail Evaluating the Efficacy of Weekly Cetuximab, Paclitaxol, Carboplatin and Daily RT in Esophageal Cancer. 46th Annual Scientific Meeting of the American Society for Therapeutic Radiology and Oncology November, 2006
6. A Phase II Trial Evaluating the Efficacy of Weekly Cetuximab, Paclitaxol, Carboplatin and Daily RT in Esophageal Cancer 48th Annual Meeting of the American Society for Therapeutic Radiology and Oncology (ASTRO) November, 2006
7. Long-Term Clinical Follow-Up of the Phase III Randomized Trial (START) Evaluating the Role of Beta Radiation for the Treatment of In-Stent Restensosis 45th Annual Scientific Meeting of the American Society for Therapeutic Radiology and Oncology October, 2005
8. The Evaluation of Amifostine for Mucosal Protection in Advanced Loco-Regional Squamous Cell Carcinomas of the Head and Neck (SCCHN) Treatment with Concurrent Weekly Carboplatin, Paclitaxel, and Daily Radiotherapy (RT) American Society of Therapeutic Radiology and Oncology (ASTRO) 47th Annual Meeting October, 2005
9. Trimodality Therapy in Esophageal Cancer Weill Medical College of Cornell University May, 2005
10. Future Directions in Esophageal Cancer Emory University School of Medicine March, 2005
11. Results of High Dose Chemotherapy for Esophageal Cancer Symposium for Thoracic Diseases Multidisciplinary Conference December, 2004
12. Preoperative Anemia Decreases Survival in Patients with Stage I and II Non-Small Cell Lung Cancer. 46th Annual Meeting of the American Society of Therapeutic Radiology and Oncology October, 2004
13. Staging of Esophageal Cancer in Patients Treated with Initial Chemoradiation: Findings of the Patterns of Care Study (PCS) 45th Annual Scientific Meeting of the American Society for Therapeutic Radiology and Oncology October, 2004
14. The Evolving Role of Radiation Therapy in the Management of Head and Neck Cancer Hahneman School of Medicine, Drexel University October, 2004
15. The Use of Concurrent Chemotherapy and Radiation Therapy in the Management of Head and Neck Cancer Patient 46th Annual Meeting of the American Society for Therapeutic Radiology and Oncology October, 2004
16. Long-Term Survival and Functional Quality of Life Assessments in Patients with Locally Advanced Unresectable Squamous Cell Carcinomas of the Head and Neck Treated with Concurrent Chemoration 45th Annual Meeting of the American Society of Therapeutic Radiology and Oncology October, 2004
17. Future Directions in the Management of Head and Neck Cancer Patients Oncology Ground Rounds, The Reading Hospital September, 2004
18. The Value of Surgery Following Chemoradiation for Patients with Esophageal Cancer Southern Association of Oncology Annual Meeting August, 2004
19. The Role of Tri-Modality in Patients Presenting with Esophageal Cancer American Association of Thoracic Surgery Annual Meeting. April, 2004
20. The Role of Tri-Modality Therapy in the Management of Esophageal Carcinoma Symposium for Thoracic Diseases Multidisciplinary Conference December, 2003
21. Outcome Results of the 1996-1999 Patterns of Care Survey of the National Practice for Patients Receiving Radiation Therapy for Carcinoma of the Esophagus 89th Annual Meeting of Radiological Society of North America Special Focus Session – ASTRO Invited Papers December, 2003
22. Clinical Applications of Intensity-Modulated Radiation Therapy University of Colorado Radiation Oncology Grand Rounds December, 2003
23. Recent Innovations in Radiation Oncology and Paradigm Changes Washington D.C. Veterans Administration Hospital Medical Grand Rounds November, 2003
24. The Role of Radiation Therapy in the Management of Patients Presenting with Non-Small Cell Lung Cancer The Johns Hopkins Lung Cancer Symposium November, 2003
25. Combined Modality Management of Head and Neck Cancer Educational Symposium at the American Society of Therapeutic Radiation and Oncology Annual Meeting October, 2003
26. Outcome Results of the 1996-1999 Patterns of Care Survey of the National Practice for Patients Receiving Radiation Therapy for Carcinoma of the Esophagus 44th Annual Scientific Meeting of the American Society for Therapeutic Radiology and Oncology October, 2003
27. The Role of Combined Modality Therapy for Locally Advanced Squamous Cell Carcinomas of the Head and Neck Grand Rounds of the Cancer Center at Wake Forest University Medical School October, 2003
28. Clinical Implementation of an Intensity-Modulated Radiation Therapy Program Annual Meeting of the Atlanta Oncology Associates August, 2003
29. The Role of Functional Imaging in Radiation Oncology Research Strategies Elekta Users Meeting May, 2003
30. Analysis of Clinical Outcomes from the START and START 40 Trials: The Efficacy of Sr-90 Radiation in the Treatment of Long Lesion In Stent Restenosis 43rd Annual Scientific Meeting of the American Society for Therapeutic Radiology and Oncology November, 2002
31. The National Standards of Practice for Patients Receiving Radiation Therapy for Carcinoma of the Esophagus: Results of the 1996-1999 Patterns of Care Study 44th Annual Scientific Meeting of the American Society for Therapeutic Radiology and Oncology October, 2002
32. Current Trends in the Management of Locally Advanced Carcinomas of the Head and Neck Virginia Regional Cancer Meeting June, 2002
33. Current Trends in the Management of Locally Advanced Carcinomas of the Head and Neck Carolina Regional Tumor Conference June, 2002
34. Concomitant Boost RT as Part of an Induction Regimen Followed by Surgery and Adjuvant Docetaxel for Locally Advanced Esophageal Cancer 38th Annual Meeting of the American Society of Clinical Oncology May, 2002
35. The University of Maryland Experience with Chemoradiation in Locally Advanced Head and Neck Cancer Fox Chase Cancer Center Investigator Workshop March, 2002
36. Combined Modality Therapy for Patients Presenting with Locally Advanced, Non-Small Cell Lung Cancer Thoracic Diseases in the New Millennium Multidisciplinary Conference December, 2001
37. The Role of Endovascular Brachytherapy in the Management of In-Stent Restenosis 2001 Scientific Symposium of the Delaware Valley Chapter of the American Association of Physicists in Medicine Meeting, Jefferson Medical College December, 2001
38. Endovascular Brachytherapy Scientific Session 43rd Annual Meeting of the Association for Therapeutic Radiology and Oncology November, 2001
39. Combined Modality Management of Head and Neck Cancer Educational Symposium at the American Society of Therapeutic Radiation and Oncology Annual Meeting November, 2001
40. Clinical Applications of Intensity-Modulated Radiation Therapy Gulf Coast Oncology Center November, 2001
41. The Role of Staging in the Treatment of Esophageal Cancer with Pre-Operative Chemotherapy and Radiation Simon Kramer Institute Symposium for the Development of a New Staging System for Esophageal Cancer August, 2001
42. Co-Moderator The Annual Simon Kramer Institute Symposium for the Development of a New Staging System for Esophageal Cancer August, 2001
43. The Importance of Accurate Lymph Node Assessment Prior to Tri-Modality Therapy in Patients Presenting with Esophageal Cancer 83rd Annual American Radium Society April, 2001
44. Patient and Personnel Radiation Exposure During Intravascular Brachytherapy: A Single Institutional Experience with Strontium-90 Isotope American Heart Association Meeting November, 2000
45. Innovations in Radiation Oncology Greenebaum Cancer Center Program in Oncology, Cancer Update 2000 November, 2000
46. Implementation of a Vascular Brachytherapy Program Transcatheter Therapeutics National Meeting October, 2000
47. Moderator - Scientific Session on Coronary Vascular Radiation 42nd Annual Meeting of the American Society for Therapeutic Radiology and Oncology October, 2000
48. Simplified Intensity Modulated Arc Therapy for Prostate Cancer Treatments American Society of Therapeutic Radiology and Oncology 42nd Annual Meeting October, 2000
49. Gamma Knife Stereotactic Radiosurgery for Synchronous Versus Metachronous Solitary Brain Metastases from Non-Small Cell Lung Cancer The American Society of Therapeutic Radiology and Oncology 42nd Annual Meeting October, 2000
50. Combination of Adenovirus p16 (INK4A) Gene Therapy and Ionizing Radiation for Squamous Cell Carcinomas of the Head and Neck. 42nd Annual Scientific Meeting of the American society for Therapeutic Radiology and Oncology October, 2000
51. Clinical Outcomes and Dose Analysis of the Effect of Beta Radiation for the Management of In-Stent Restenosis: Results of the Stents and Radiation Therapy Randomized Trial (START) 42nd Annual Scientific Meeting of the American Society for Therapeutic Radiology and Oncology (ASTRO) October, 2000
52. IMRT Delivery Approaches and Clinical Experience with IMAT (Intensity Modulated Radiation Therapy) Elekta Symposium on Advanced Clinical Solutions in Conformal Radiotherapy (IMRT) and Gamma Knife Surgery, American Society of Therapeutic Radiology and Oncology 42nd Annual Meeting October, 2000
53. Innovations in the Use of Radiotherapy for Head and Neck Cancer 5th Annual National VA Oncology Symposium. October, 2000
54. Multi-Modality Treatment for Early Stage Head and Neck Carcinomas Bristol-Myers Squibb Oncology Physician Speakers Training Program October, 2000
55. Combining Radiation and Chemotherapy in the Treatment of Head and Neck Carcinomas Oncology Ground Rounds, University of Louisville August, 2000
56. Advances in the Treatment of Head and Neck Cancer Cancer Center Ground Rounds, Divine Providence Hospital August, 2000
57. The Role of Radiation in the Prevention of Coronary Artery Restenosis Department of Radiation Oncology and Combining Radiation and Chemotherapy in the Treatment of Head and Neck Carcinomas August, 2000
58. Pre-Treatment Hemoglobin is Associated with Response to Chemoradiation (CRT) in Patients with Advanced Unresectable Squamous Cell Carcinoma of the Head and Neck American Society of Clinical Oncology Annual Meeting May, 2000
59. The Role of Radiation in the Prevention of Vascular Restenosis Device Workshop atthe Society of Cardiac Angiography and Interventions Meeting May, 2000
60. The Role of Vascular Brachytherapy in the Prevention of Coronary Artery Restenosis theAmerican College of Medical Physicist (ACMP) Annual Meeting May, 2000
61. The Use of Concurrent Chemotherapy and Radiation Prior to Surgical Resection in Patients Presenting with Apical Sulcus Tumors 82nd Annual Meeting of the American Radium Society April, 2000
62. Radiation Therapy with Concurrent Weekly Carboplatin and Paclitaxel in Advanced Stage Unresectable Squamous Cell Carcinomas of the Head and Neck Fox Chase Cancer Center Investigator Workshop March, 2000
63. Clinical Implementation of Intensity-Modulated Arc Therapy International Symposium on Intensity-Modulated Radiation Therapy March, 2000
64. Chemo-Radiation Prior to Surgical Resection for Patients Presenting with Advanced Non-Small Cell Cancers of the Lung Symposium for Thoracic Diseases Multi-Disciplinary Conference December, 1999
65. Advances in the Management of Esophageal Carcinoma Symposium for Thoracic Diseases Multidisciplinary Conference December, 1999
66. Multidisciplinary Treatment of Non-Small Cell Lung Cancer University of Maryland CME Program October, 1999
67. Evaluation of Response and Survival in Unresectable SCCHN Treated with Chemoradiation on Three Consecutive Institutional Trials First International Chicago Symposium on Malignancies of the Chest, Head and Neck October, 1999
68. The Use of Radiation Therapy to Prevent Coronary Artery Restenosis Radiation Oncology Ground Rounds, Rush Presbyterian Hospital July, 1998
69. The University of Maryland Experience with the Beta Cath Trial Novosote European Investigators Meeting June, 1998
70. Endoscopic Assessment of Tumor Viability After Combined Chemoradiation for Esophageal Cancer Annual Meeting of the American Society of Gastrointestinal Endoscopists, Digestive Disorders Week May, 1998
71. Localization of Tirapazamine Induced DNA Damage in RIF-1 Multi-Cell Spheroids; in Situ Alkaline Comet Assay (ISACA). Radiation Research Society Meeting May, 1998
72. The Role of Brachytherapy in the Prevention of Coronary Artery Restenosis Medical Ground Rounds for the School of Medicine, University of Maryland, Department of Medicine November, 1997
73. Important Predictors of Response Determined by Surgical Stating Prior to Triple Modality Therapy for Esophageal Cancer 39th Annual Scientific Meeting of the American Society for Therapeutic Radiology and Oncology (ASTRO) October, 1997
74. Staging and Combined Modality Treatment for Esophgeal Cancer Radiation Oncology with Tri-Modality Treatment Panel Discussion Multidisciplinary Treatment of Solid Tumors Conference September, 1997
75. Treatment Role of Radiation Therapy in the Management of Patients with Localized Advanced NSCLS Recent Advances in the Treatment of Ovarian Cancer and Lung Cancer Conference June, 1997
76. A Constant Level of HSP70 During a Transitional Period from a Heat-Sensitive to a Heat-Resistant State Following Dispersion of RIF-1 Spheroids North American Hyperthermia Society Meeting May, 1997
77. Management of Bulky Lymph Nodes as Part of Combined Modality Therapy for Advanced Head and Neck Cancers Southern Medical Association Annual Meeting November, 1996
78. Organ Preservation in Advanced Larynx Cancer: A Radiation Oncologist’s Perspective Southern Medical Association Annual Meeting November, 1996
79. Conformal Radiation Therapy University of Maryland Cancer Center Spring Conference on Advances in Cancer Care June, 1996
80. Review of Current RTOG Head and Neck Protocols Ground Rounds in the Hematology/Medical Oncology Conference, University of Maryland Cancer Center May, 1996
81. Reoxygenation Patterns of RIF-1 Multi-Cell Spheroids Determined by Halo and Halo-Comet Assays Following SR-4233 Exposures Radiation Research Society Meeting April, 1996
82. Future Trends in the Management of Esophageal Cancers Ground Rounds in the Department of Radiation Oncology, University of Maryland September, 1995
83. A Radiobiologic Evaluation of Overall Treatment Time in Patients with Early Stage Glottic Carcinoma The American Radium Society Annual Meeting April, 1995
84. Reoxygenation Kinetics in RIF-1 Multi-Cell Spheroids Characterized by the Changes in Cytotoxicity of X-Rays and SR-4233, A Hypoxic Cell Toxin American Society for Therapeutic Radiology and Oncology Annual Meeting October, 1994
85. The Use of Radiotherapy in the Management of Early Stage Glottic Carcinoma Ground Rounds in the Department of Radiation Oncology, University of Maryland June, 1994
86. Preliminary Results of I125 Implantation for Early Stage Prostate Cancer National Cancer Institute Radiation Oncology Grand Rounds December, 1992
87. Technical Considerations of Ultrasound and Template Guided I125 Implantation for Early Stage Prostate Cancer Mid-Atlantic Society for Radiation Oncology Meeting September, 1992
88. Radiation Modifiers: From Discovery to Reality 8th Biennial Meeting of Circulo De Radioterapeutas Ibero Latino Americans (CRILA) May, 1992



Site wide Speaking/Presenting-Abstract/Poster at Mtg

No events found.
4th Annual Pharma R&D Asia Congress
About Us | Privacy Policy | Site Map | FAQs | Advertise With Us | Community
BiotechScienceNews.com promotes research and ranks life scientists working in the life science spectrum involving biotechnology,
drug discovery, genomics, microbiology, neuroscience, medicine, pharmacology, cell biology, and molecular biology.